$50.00
Brilinta® (ticagrelor) 90 mg Tablets – Bottle of 60
Product Description: Brilinta® is a prescription antiplatelet medicine containing ticagrelor, designed to help prevent blood clots that can lead to serious cardiovascular events such as heart attack, stroke, or death. It is primarily used in adults with acute coronary syndrome (ACS) or a history of myocardial infarction (MI). Brilinta works by inhibiting platelet aggregation, reducing the risk of new clot formation.
Product Features:
Active Ingredient: Ticagrelor
Strength: 90 mg per tablet
Dosage Form: Film-coated oral tablet
Quantity: Bottle of 60 tablets
Administration: Typically 90 mg twice daily, along with low-dose aspirin
Route of Administration: Oral
Indications:
Treatment of Acute Coronary Syndrome (ACS), including unstable angina and myocardial infarction with or without stenting
Reduction of thrombotic cardiovascular events in patients with a history of heart attack
Used as part of dual antiplatelet therapy (DAPT) with aspirin, usually for the first 12 months following ACS
Reviews
There are no reviews yet.